Patent ID: 11917960
Assignee: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Field: Biotechnology (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 1:
2. The method according to claim 1, wherein the CIM has one or more or all of the following features:
(i) the one or more auxins are selected from the group consisting of indole-3-acetic acid (IAA), 4-chloroindole-3-acetic acid, phenylacetic acid, indole-3-butyric acid (IBA), 1-naphthaleneacetic acid (NAA), 2-naphthoxyacetic acid, 4-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid, 2,3,5-triiodobenzoic acid, picloram, and salt forms of any one thereof;
(ii) the one or more auxins are present in the CIM at a concentration of 0.1 mg/L to 5 mg/L;
(iii) the one or more cytokinins are selected from the group consisting of benzylaminopurine (BAP), zeatin, kinetin, 2IP, zeatin riboside, diphenylurea and thidiazuron (TDZ);
(iv) the one or more cytokinins are present in the CIM at a concentration of 0.01 mg/L to 2 mg/L;
(v) the one or more auxins and the one or more cytokinins are present in the CIM in amounts relative to one another which is sufficient to produce and/or maintain the DECs from the IEs; and
(vi) the one or more auxins and the one or more cytokinins are present in the CIM at a weight ratio (auxin:cytokinin) of 2:1.